CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $342,072,960
- in 74 filings, $341.3M under 10b5-1 plans
Net −$342,072,960. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-19 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −360 | $536.36 | $193K | 333,423 |
| 2026-10-19 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −240 | $537.11 | $129K | 333,183 |
| 2026-10-19 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −160 | $538.54 | $86K | 333,023 |
| 2026-10-19 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −880 | $539.79 | $475K | 332,143 |
| 2026-10-19 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,800 | $540.63 | $973K | 330,343 |
| 2026-10-19 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −520 | $541.38 | $282K | 329,823 |
| 2026-10-19 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −260 | $542.81 | $141K | 329,563 |
| 2026-10-19 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,240 | $543.73 | $674K | 328,323 |
| 2026-10-19 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,040 | $544.89 | $567K | 327,283 |
| 2026-10-19 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,065 | $545.90 | $581K | 326,218 |
| 2026-10-19 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −416 | $547.00 | $228K | 325,802 |
| 2026-10-19 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −559 | $547.98 | $306K | 325,243 |
| 2026-10-19 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −360 | $549.01 | $198K | 324,883 |
| 2026-10-19 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −120 | $549.66 | $66K | 324,763 |
| 2026-10-19 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −80 | $551.78 | $44K | 324,683 |
| 2026-10-19 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −40 | $552.78 | $22K | 324,643 |
| 2026-10-19 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −120 | $554.00 | $66K | 324,523 |
| 2026-10-19 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −80 | $556.88 | $45K | 324,443 |
| 2026-10-19 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 204,910 | ||
| 2026-10-16 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $117.76 | $1.1M | 333,943 |
Page 16 of 81 · 1,617 trades